rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

532321 CADILAHC Group (A)

Cadila Healthcare Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1206.00   14.00   1.17%
Volume 26,394
Prev close 1,192.00
Day's H/L (Rs.) 1,239.00 - 1,190.00
52wk H/L (Rs.) 1,239.00 - 631.00
Mkt Cap (Rs. Cr) 24,686.82
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

CADILAHC

Cadila Healthcare Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1215.00   19.75   1.65%
Volume 355,665
Prev close 1195.25
Day's H/L (Rs.) 1,241.90 - 1,197.30
52wk H/L (Rs.) 1,241.90 - 629.00
Turnover (Rs. Lacs) 4,363.94
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Cadila Healthcare Ltd.  (See all 149 market voices)   

140 Characters
  Cancel
Expert Voices - 5 day(s) ago
#Cadila-Healthcare-Ltd
: Zydus gets US FDA approval for Potassium Citrate ER tablets, used in prevention of Kidney Stones. Potassium Citrate ER tablets est sales at $131.7 mn in 2014. (CNBC-TV18)
Reply   |   Share
Rajeev - 1 day(s) ago TOP 5 STOCKS TO BUY NOW....BEST STOCKS TO PICK…WITH 90% ACCURACY GET BUY/SELL ALERTS ON MOBILE - VISIT http://rediff.ly/2xft7 or CALL 9713333037
#Cadila-Healthcare-Ltd
Reply   |   Share
Algernon - 1 day ago  
#Igarashi
Motors: Buy - 222 goals - 240, stoploss - 220
#RCF
: Buy - 60 goals - 70, stoploss - 59
#Equity
held: Buy - 137 goals - 147, stoploss - 135.CLICK HERE -- http://rediff.ly/3ekgo
Reply   |  Share

Realtime news for Cadila Healthcare Ltd. (See all 352 news)

21 August 2014, 07:54
Zydus Cadila gets USFDA approval for anti-viral drug Acyclovir - 17 hour(s) ago
Cadila Healthcare trades with traction on the bourses - 18 hour(s) ago
Cadila Healthcare jumps after USFDA OK for anti-viral drug - 17 hour(s) ago
Cadila Health at new high on USFDA nod for anti-viral drug - 18 hour(s) ago
OPPI Healthcare Summit suggests increasing access to healthcare through policy interventions - 12 Aug 2014

BSE Announcements from Cadila Healthcare Ltd. (See all)

Zydus receives final approval for Acyclovir Tablets - 1 day(s) ago
Investor Presentation - 14 Aug 2014

Company details for Cadila Healthcare Ltd.

Report Card

PE Ratios
26.22
EPS (Rs.)
44.13
Sales (Rs. Cr)
1,112.79
Face Value (Rs.)
5
Net Profit
Margin (%)
 
20.76
Last Bonus
1:2
Last Dividend(%)
180
Return on
Average Equity
 
24.89

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Cadila Healthcare Ltd. performance snapshot

If you had invested Rs.  in Cadila Healthcare Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Cadila Healthcare Ltd. with other stocks

Apollo Hospitals Enterprise Ltd.
1,119.55
Lupin Ltd.
1,200.50
Show more companies
Apollo Hospitals Enterprise Ltd.
1,119.55
Lupin Ltd.
1,200.50
Piramal Enterprises Ltd.
690.90
Ranbaxy Laboratories Ltd.
604.30
Biocon Ltd.
469.55
Glenmark Pharmaceuticals Ltd.
727.15
Dr. Reddy's Laboratories Ltd.
2,773.25
GlaxoSmithKline Pharmaceuticals Ltd.
2,493.60
Strides Arcolab Ltd.
649.50
Cipla Ltd.
469.75
Show less companies
Close
Add Cadila Healthcare Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Cadila Healthcare Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close